Ovarian Function Following Intraovarian Injection of PRP
Running, not enrolling · Not applicable
Conditions studied: Diminished Ovarian Reserve, Diminished Ovarian Reserve Due to Advanced Maternal Age
In brief
Consenting women with evidence of poor ovarian reserve will be randomly assigned to treatment with either Platelet Rich Plasma (PRP) or Platelet Poor Plasma (PPP).
Key facts
- Study ID
- NCT04278313
- Run by
- Center for Human Reproduction
- People needed
- 90
- Starts
- 2020-02-24
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-01-16
Who can join
Age: 21 and older, up to 44. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- fewer than 6 oocytes in response to past ovulation induction
- desire to establish a pregnancy using IVF
- Age 44 years and under.
- FSH > 12
- AMH < 1.0
- No Aspirin or Motrin for one week before treatment
You may not qualify if…
- Age > 45 years
- Marked thrombocytopenia
- Blood diseases
- Hypofibrinogenemia
- Hemodynamic instability
- Anticoagulant or antiaggregant treatment
- Oncological diseases (specially, skeletal system and blood)
- Sepsis
- Acute and chronic infectious diseases
- Autoimmune diseases, for example, lupus erythematosus, etc.
Where it is running
- Center for Human Reproduction — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.